13F filing recap · Q1 2013
What did Lone Pine Capital buy in Q1 2013?
Reported stock-position changes between this filing and the previous one.
Stock value
$18.96B
Positions
52
Estimated turnover
29.1%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
VRXValeant Pharmaceuticals International, Inc.$368.54Mreported value+4.91M sharesVMEDVirgin Media Inc$277.16Mreported value+5.66M sharesTMOThermo Fisher Scientific Inc.$217.77Mreported value+2.85M sharesCMECme Group Inc.$217.49Mreported value+3.54M sharesLMCALiberty Media Corporation$214.15Mreported value+1.92M sharesHRBH&R Block, Inc.$198.73Mreported value+6.75M sharesSBHSally Beauty Holdings, Inc.$181.45Mreported value+6.18M sharesGRAW.r. Grace & Co.$115.79Mreported value+1.49M sharesNBISNebius Group N.v.$39.48Mreported value+1.71M shares